Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| INSR | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 6.35E4 | Evidence |
|
||||
| INSR | CRKL | CRKL: Crk-like protein | 6.35E4 | Evidence |
|
||||
| INSR | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 6.35E4 | Evidence |
|
||||
| INSR | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 5.39E4 | Evidence | |||||
| INSR | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 3.97E4 | Evidence |
|
||||
| INSR | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 1.63E4 | Evidence |
|
||||
| INSR | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 1.74E3 | Evidence |
|
||||
| INSR | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 200.0 | Evidence | |||||
| INSR | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 200.0 | Evidence | |||||
| INSR | STAT3 | 200.0 | Evidence | ||||||
| INSR | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 147.0 | Evidence | |||||
| INSR | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 147.0 | Evidence | |||||
| INSR | GRB10 | N/A | 141.0 | Evidence |
|
||||
| INSR | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 135.0 | Evidence |
|
||||
| INSR | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 132.0 | Evidence | |||||
| INSR | SYK | SYK: Tyrosine-protein kinase SYK | 132.0 | Evidence | |||||
| INSR | LYN | LYN: Tyrosine-protein kinase Lyn | 132.0 | Evidence | |||||
| INSR | BMX | N/A | 125.0 | Evidence | |||||
| INSR | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 110.0 | Evidence | |||||
| INSR | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 101.0 | Evidence |
|
||||
| INSR | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 101.0 | Evidence |
|
||||
| INSR | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 89.30 | Evidence | |||||
| INSR | CRK | CRK: Proto-oncogene C-crk | 85.60 | Evidence |
|
||||
| INSR | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 80.50 | Evidence | |||||
| INSR | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 80.00 | Evidence | |||||
| INSR | APS | SH2B2, APS: SH2B adapter protein 2 | 80.00 | Evidence |
|
||||
| INSR | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 80.00 | Evidence | |||||
| INSR | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 80.00 | Evidence | |||||
| INSR | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 80.00 | Evidence | |||||
| INSR | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 79.90 | Evidence |
|
||||
| INSR | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 72.70 | Evidence |
|
||||
| INSR | VAV1 | VAV1, VAV: Proto-oncogene vav | 72.10 | Evidence |
|
||||
| INSR | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 72.10 | Evidence | |||||
| INSR | JAK1 | 72.10 | Evidence |
|
|||||
| INSR | NCK2 | NCK2: Cytoplasmic protein NCK2 | 62.10 | Evidence | |||||
| INSR | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 55.80 | Evidence | |||||
| INSR | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 53.20 | Evidence | |||||
| INSR | GRAP | GRAP: GRB2-related adapter protein | 53.20 | Evidence | |||||
| INSR | RIN1 | RIN1: Ras and Rab interactor 1 | 52.50 | Evidence | |||||
| INSR | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 52.50 | Evidence | |||||
| INSR | HCK | N/A | 52.50 | Evidence | |||||
| INSR | GNAI3 | GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha | 49.00 | Evidence | |||||
| INSR | CSK | CSK: Tyrosine-protein kinase CSK | 47.30 | Evidence |
|
||||
| INSR | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 44.10 | Evidence | |||||
| INSR | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 43.60 | Evidence | |||||
| INSR | EHD4 | EHD4, HCA10, FKSG7, HCA11, PAST4: EH domain-containing protein 4 | 40.60 | Evidence | |||||
| INSR | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 39.10 | Evidence | |||||
| INSR | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 37.80 | Evidence | |||||
| INSR | ADAM33 | ADAM33, UNQ873/PRO1891: ADAM 33 precursor | 33.90 | Evidence | |||||
| INSR | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 33.90 | Evidence | |||||
| INSR | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 31.20 | Evidence | |||||
| INSR | GNAO1 | GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 | 31.10 | Evidence | |||||
| INSR | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 29.30 | Evidence |
|
||||
| INSR | EPOR | EPOR: Erythropoietin receptor precursor | 28.20 | Evidence | |||||
| INSR | GHR | GHR: Growth hormone receptor precursor | 28.20 | Evidence | |||||
| INSR | IL12RB2 | IL12RB2: Interleukin-12 receptor beta-2 chain precursor | 28.20 | Evidence | |||||
| INSR | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 28.20 | Evidence | |||||
| INSR | KIT | KIT: Mast/stem cell growth factor receptor precursor | 25.3 | Evidence | |||||
| INSR | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 25.3 | Evidence |
|
||||
| INSR | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 24.80 | Evidence | |||||
| INSR | GNAT1 | GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit | 23.20 | Evidence | |||||
| INSR | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 22.90 | Evidence | |||||
| INSR | LEPR | LEPR, DB, OBR: Leptin receptor precursor | 22.90 | Evidence | |||||
| INSR | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 22.90 | Evidence |
|
||||
| INSR | IL4R | IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor | 22.90 | Evidence | |||||
| INSR | AP1GBP1 | AP1GBP1, SYNG: AP1 subunit gamma-binding protein 1 | 22.30 | Evidence | |||||
| INSR | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 22.20 | Evidence | |||||
| INSR | ROBO1 | ROBO1, DUTT1: Roundabout homolog 1 precursor | 22.20 | Evidence | |||||
| INSR | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 22.20 | Evidence |
|
||||
| INSR | DAB2 | DAB2, DOC2: Disabled homolog 2 | 21.60 | Evidence | |||||
| INSR | PRLR | PRLR: Prolactin receptor precursor | 21.10 | Evidence | |||||
| INSR | TRPM7 | TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me | 20.50 | Evidence | |||||
| INSR | PTPRF | PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor | 20.50 | Evidence |
|
||||
| INSR | GNAT2 | GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit | 20.40 | Evidence | |||||
| INSR | GNAI1 | GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit | 20.40 | Evidence | |||||
| INSR | GNAZ | GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha | 20.40 | Evidence | |||||
| INSR | CNTN2 | CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor | 20.00 | Evidence | |||||
| INSR | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 19.70 | Evidence | |||||
| INSR | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 19.70 | Evidence | |||||
| INSR | CCR2 | CCR2, CMKBR2: C-C chemokine receptor type 2 | 19.10 | Evidence | |||||
| INSR | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 18.90 | Evidence | |||||
| INSR | S100A3 | S100A3, S100E: Protein S100-A3 | 18.60 | Evidence | |||||
| INSR | SPTA1 | SPTA1, SPTA: Spectrin alpha chain, erythrocyte | 18.60 | Evidence | |||||
| INSR | AGTR1 | AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor | 17.60 | Evidence | |||||
| INSR | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 17.10 | Evidence | |||||
| INSR | MPL | MPL, TPOR: Thrombopoietin receptor precursor | 17.10 | Evidence | |||||
| INSR | STAM2 | STAM2: Signal transducing adapter molecule 2 | 16.60 | Evidence | |||||
| INSR | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 16.40 | Evidence | |||||
| INSR | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 15.50 | Evidence | |||||
| INSR | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 15.30 | Evidence | |||||
| INSR | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 15.30 | Evidence | |||||
| INSR | ITSN1 | ITSN1, ITSN, SH3D1A: Intersectin-1 | 15.10 | Evidence | |||||
| INSR | IFNGR1 | IFNGR1: Interferon-gamma receptor alpha chain precursor | 15.00 | Evidence | |||||
| INSR | HLA-DMB | HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec | 15.00 | Evidence | |||||
| INSR | CD1A | CD1A: T-cell surface glycoprotein CD1a precursor | 15.00 | Evidence | |||||
| INSR | SELE | SELE, ELAM1: E-selectin precursor | 15.00 | Evidence | |||||
| INSR | MYL4 | MYL4, MLC1, PRO1957: Myosin light polypeptide 4 | 14.60 | Evidence | |||||
| INSR | IRS2 | IRS2: Insulin receptor substrate 2 | 13.90 | Evidence |
|
||||
| INSR | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 13.60 | Evidence | |||||
| INSR | CD28 | CD28: T-cell-specific surface glycoprotein CD28 precursor | 13.50 | Evidence | |||||
| INSR | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 13.50 | Evidence | |||||
| INSR | NEDD9 | NEDD9, CASL: Enhancer of filamentation 1 | 13.50 | Evidence | |||||
| INSR | LATS1 | LATS1, WARTS: Serine/threonine-protein kinase LATS1 | 13.50 | Evidence | |||||
| INSR | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 13.50 | Evidence | |||||
| INSR | CDC25A | CDC25A: M-phase inducer phosphatase 1 | 13.50 | Evidence | |||||
| INSR | ACTN4 | ACTN4: Alpha-actinin-4 | 13.50 | Evidence | |||||
| INSR | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 13.40 | Evidence | |||||
| INSR | EHD1 | EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 | 13.20 | Evidence | |||||